Among other things, the order requires the Food and Drug Administration to increase its reporting of possible shortages of certain prescription drugs, while also speeding up regulatory reviews of new drug manufacturing sites, drug suppliers and manufacturing changes. Drug manufacturers are being encouraged to voluntarily disclose possible prescription drug shortages in instances not currently required by law. " Obama administration officials have also sent a letter to drug manufacturers "reminding them of their responsibility to report the discontinuation of certain drugs to the FDA," the statement noted. -- President Barack Obama signed an executive order Monday designed to help reduce a growing number of prescription drug shortages while protecting patients from possible pharmaceutical industry price gouging. "The shortage of prescription drugs drives up costs, leaves consumers vulnerable to price gouging and threatens our health and safety," Obama said in a written statement.